Back to Search Start Over

577P A study of the efficacy and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in NSCLC.

Authors :
Choi, D.
Jung, H.A.
Park, S.
Sun, J-M.
Ahn, J.S.
Ahn, M-J.
Lee, S-H.
Source :
Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1696-S1696. 1p.
Publication Year :
2023

Details

Language :
English
ISSN :
09237534
Volume :
34
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
173758534
Full Text :
https://doi.org/10.1016/j.annonc.2023.10.655